C85.95 Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb

Name of the Condition

• Common Name: Non-Hodgkin Lymphoma
• Medical Term: Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb
• ICD Code: C85.95

Summary

Non-Hodgkin lymphoma (NHL) is a group of blood cancers that affect the lymphatic system, part of the immune system. This code is used when the specific subtype of NHL is not clearly defined and the lymphoma is located in the lymph nodes of the inguinal region (groin) or lower limb. The lymphatic system helps fight infections, and NHL arises from abnormal lymphocyte growth.

Causes

The exact cause of non-Hodgkin lymphoma is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections, immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., hepatitis C, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Swollen lymph nodes in the groin or lower limb
• Fever, night sweats, or unexplained weight loss
• Fatigue or weakness
• Persistent cough or chest discomfort
• Itching or skin rashes
• Abdominal pain or swelling

Diagnosis

Diagnosis typically involves a combination of physical examination, blood tests, imaging scans (CT, MRI, PET), and a lymph node biopsy. A biopsy is often required to confirm the presence of lymphoma and determine its subtype. Additional tests, such as bone marrow biopsy or flow cytometry, may be used to assess the extent of the disease.

Treatment Options

• Chemotherapy: Uses drugs to destroy cancer cells, often the primary treatment for NHL.
• Radiation therapy: Targets specific areas, such as the inguinal region or lower limb, to reduce tumor size.
• Immunotherapy: Enhances the immune system to fight cancer cells.
• Targeted therapy: Uses drugs to target specific molecules involved in cancer growth.
• Stem cell transplant: May be considered for aggressive or relapsed cases.

Prognosis and Follow-Up

Prognosis depends on factors like the subtype, stage, and patient age. Early-stage disease generally has a better outlook. Follow-up care includes regular monitoring with imaging, blood tests, and physical exams to detect recurrence or complications. Long-term survivors may require ongoing surveillance for late effects of treatment.

Complications

• Recurrence of lymphoma
• Infection due to weakened immune system
• Side effects from treatment (e.g., fatigue, nausea, organ damage)
• Secondary cancers (e.g., leukemia) from chemotherapy or radiation
• Lymphedema (swelling) in the lower limb

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Avoid exposure to known carcinogens, such as tobacco or certain chemicals.
• Practice good hygiene to reduce infection risk.
• Stay up-to-date with vaccinations, as recommended by a healthcare provider.

When to Seek Professional Help

Seek medical attention if you experience persistent swollen lymph nodes, unexplained weight loss, fever, or fatigue. Prompt evaluation is important for early diagnosis and treatment. Contact a healthcare provider if symptoms worsen or new symptoms develop.

Tips for Medical Coders

Use code C85.95 when documenting non-Hodgkin lymphoma with an unspecified subtype located in the lymph nodes of the inguinal region or lower limb. Ensure the medical record specifies the anatomical site to support this code. If the subtype is known, use a more specific code. Verify that the documentation aligns with the code's description to avoid miscoding.